Sekce: Daily overview

Selection from Decision-Making Practice – 28/2026

Non-Interchangeability of Tablets (VILP) and Oral Solution (Orphan Medicinal Product) Containing the Same Active Substance
Pharmeca a.s. 11/20/2026
Sekce: Daily overview

Selection from Decision-Making Practice – 27/2026

The Scope of Financial Agreements Also Affects Prescribing Restrictions.
Pharmeca a.s. 11/12/2026
Sekce: Daily overview

Selection from Decision-Making Practice – 26/2026

Lower Reimbursement Limit Based on JUHR2.
Pharmeca a.s. 11/04/2026
Sekce: Focused on

Key Changes to Drug Reimbursement in Slovakia

Slovakia is continuing to amend its legislative framework governing the reimbursement of medicinal products and medical devices under the public health insurance system. The first changes will take...
Pharmeca a.s. 10/30/2026
Sekce: Daily overview

Selection from Decision-Making Practice – 25/2026

Ministry of Health Rules on Reimbursement of Administrative Expenses.
Pharmeca a.s. 10/29/2026
Sekce: Daily overview

Selection from Decision-Making Practice – 24/2026

Removal of Price Information from Trade Secret Protection.
Pharmeca a.s. 10/21/2026
Sekce: Daily overview

Selection from Decision-Making Practice – 23/2026

Agreements with Payers Should Ensure Compliance with Cost-Effectiveness Requirements.
Pharmeca a.s. 10/15/2026
Sekce: Daily overview

Selection from Decision-Making Practice – 22/2026

Reimbursement May Be Discontinued Even When the Medicinal Product Is Available.
Pharmeca a.s. 10/08/2026